Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig00801 |
alpha- muscle-specific form gp220 |
1671 |
20 |
3.49E-83 |
82.60% |
7 |
C:cytoplasm; F:transcription coactivator activity; F:DNA binding; F:TATA-binding protein binding; C:nucleus; P:regulation of transcription, DNA-dependent; P:protein transport |
|
|
contig00802 |
chromobox homolog 8 (pc class drosophila) |
897 |
20 |
3.73E-84 |
75.10% |
8 |
C:PcG protein complex; P:histone ubiquitination; P:chromatin silencing; F:ubiquitin-protein ligase activity; C:chromatin; F:protein binding; C:ubiquitin ligase complex; F:chromatin binding |
EC:6.3.2.19 |
|
contig00803 |
---NA--- |
350 |
0 |
|
|
0 |
|
|
|
contig00804 |
ribosomal protein l10 |
831 |
20 |
1.36E-122 |
96.60% |
6 |
P:spermatogenesis; F:structural constituent of ribosome; C:large ribosomal subunit; C:nucleus; P:translation; C:endoplasmic reticulum |
EC:3.6.5.3 |
|
contig00805 |
set and mynd domain containing 3 |
627 |
20 |
2.87E-61 |
64.00% |
1 |
F:protein binding |
|
|
contig00806 |
---NA--- |
675 |
0 |
|
|
0 |
|
|
|
contig00807 |
---NA--- |
772 |
0 |
|
|
0 |
|
|
|
contig00808 |
---NA--- |
569 |
0 |
|
|
0 |
|
|
|
contig00809 |
nadh dehydrogenase 1 alpha 42kda |
1267 |
20 |
2.43E-152 |
77.70% |
7 |
F:binding; F:NADH dehydrogenase (ubiquinone) activity; C:mitochondrial respiratory chain complex I; P:ubiquinone biosynthetic process; F:phosphotransferase activity, alcohol group as acceptor; P:mitochondrial electron transport, NADH to ubiquinone; P:nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
EC:1.6.5.3; EC:2.7.1.0 |
|
contig00810 |
mgc86401 protein |
693 |
20 |
7.99E-21 |
55.95% |
3 |
P:triglyceride catabolic process; F:triglyceride lipase activity; C:cytosol |
EC:3.1.1.3 |
|
contig00811 |
programmed cell death 8 (apoptosis-inducing factor) |
1819 |
11 |
8.47E-30 |
63.36% |
3 |
P:cell redox homeostasis; F:oxidoreductase activity; F:FAD binding |
|
|
contig00812 |
---NA--- |
291 |
0 |
|
|
0 |
|
|
|
contig00813 |
---NA--- |
488 |
0 |
|
|
0 |
|
|
|
contig00814 |
glyceraldehyde-3-phosphate dehydrogenase |
248 |
20 |
1.22E-28 |
95.90% |
4 |
C:cytoplasm; F:NAD or NADH binding; P:glycolysis; F:glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity |
EC:1.2.1.12 |
|
contig00815 |
microfibrillar-associated protein 1 |
1012 |
20 |
3.85E-83 |
94.20% |
2 |
F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix |
|
|
contig00816 |
cleavage and polyadenylation specificity factor isoform cra_b |
291 |
20 |
3.15E-48 |
100.00% |
5 |
P:mRNA polyadenylation; F:endonuclease activity; C:mRNA cleavage and polyadenylation specificity factor complex; F:mRNA binding; F:zinc ion binding |
|
|
contig00817 |
guanine nucleotide binding 3 |
462 |
20 |
4.30E-29 |
73.95% |
2 |
C:nucleolus; F:nucleotide binding |
|
|
contig00818 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig00819 |
ectodysplasin [Gasterosteus aculeatus] |
334 |
2 |
1.15E-26 |
81.00% |
5 |
P:immune response; C:membrane; C:cytoplasm; F:tumor necrosis factor receptor binding; P:phosphate transport |
|
|
contig00820 |
kinesin family member 22 |
1769 |
20 |
0 |
68.55% |
6 |
C:chromatin; C:microtubule associated complex; F:DNA binding; C:spindle; P:microtubule-based process; F:motor activity |
|
|
contig00821 |
gtp binding protein 5 |
604 |
20 |
6.21E-71 |
80.75% |
3 |
C:mitochondrion; P:ribosome biogenesis; F:GTP binding |
|
|
contig00822 |
egg membrane protein |
1390 |
20 |
2.21E-117 |
58.90% |
2 |
C:chorion; C:viral envelope |
|
|
contig00823 |
member ras oncogene family |
1064 |
20 |
9.21E-83 |
88.50% |
7 |
P:protein amino acid phosphorylation; F:GTP binding; F:protein kinase activity; F:ATP binding; P:small GTPase mediated signal transduction; C:mitochondrion; P:protein transport |
|
|
contig00824 |
eorge syndrome critical region gene 8 |
328 |
20 |
2.25E-38 |
80.15% |
5 |
C:cytoplasm; F:double-stranded RNA binding; P:primary microRNA processing; F:protein binding; C:nucleus |
|
|
contig00825 |
leydig cell tumor 10 kda protein |
428 |
7 |
2.77E-12 |
81.00% |
2 |
P:P; C:C |
|
|
contig00826 |
calcium voltage- alpha 1f subunit |
505 |
20 |
4.00E-09 |
62.95% |
6 |
F:calcium channel activity; C:protein complex; C:plasma membrane part; F:voltage-gated cation channel activity; C:integral to membrane; P:metal ion transport |
|
|
contig00827 |
nadh dehydrogenase subunit 1 |
993 |
20 |
1.41E-98 |
91.50% |
4 |
C:integral to membrane; C:mitochondrion; F:NADH dehydrogenase (ubiquinone) activity; P:electron transport |
EC:1.6.5.3 |
|
contig00828 |
proteasome ( macropain) assembly chaperone 2 |
1154 |
20 |
5.13E-98 |
73.75% |
3 |
C:nucleus; P:proteasome assembly; F:protein binding |
|
|
contig00829 |
cell death-inducing dffa-like effector c |
1068 |
20 |
3.54E-74 |
73.90% |
2 |
C:cytosol; P:induction of apoptosis |
|
|
contig00830 |
nop16 nucleolar protein homolog |
995 |
20 |
3.08E-61 |
70.30% |
1 |
C:nucleus |
|
|
contig00831 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
contig00832 |
dihydrouridine synthase 2- smm1 homolog ( cerevisiae) |
499 |
20 |
1.42E-67 |
83.20% |
5 |
F:double-stranded RNA binding; F:FAD binding; C:endoplasmic reticulum; F:tRNA dihydrouridine synthase activity; P:tRNA processing |
|
|
contig00833 |
pyruvate muscle |
281 |
20 |
5.65E-34 |
86.15% |
4 |
F:pyruvate kinase activity; F:potassium ion binding; F:magnesium ion binding; P:glycolysis |
EC:2.7.1.40 |
|
contig00834 |
rrm1 protein |
309 |
20 |
3.65E-49 |
96.10% |
5 |
C:ribonucleoside-diphosphate reductase complex; P:DNA replication; F:protein binding; F:ATP binding; F:ribonucleoside-diphosphate reductase activity |
EC:1.17.4.1 |
|
contig00835 |
---NA--- |
491 |
0 |
|
|
0 |
|
|
|
contig00836 |
regulator of chromosome condensation 2 |
429 |
20 |
1.61E-69 |
72.70% |
2 |
P:cellular process; C:intracellular organelle |
|
|
contig00837 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
contig00838 |
synaptic 2 |
577 |
20 |
1.61E-53 |
93.65% |
4 |
C:endoplasmic reticulum membrane; P:steroid biosynthetic process; F:oxidoreductase activity, acting on the CH-CH group of donors; C:integral to membrane |
|
|
contig00839 |
cornichon homolog |
1133 |
20 |
3.05E-63 |
94.75% |
6 |
C:Golgi membrane; C:endoplasmic reticulum membrane; ; P:vesicle-mediated transport; C:integral to membrane; P:immune response |
|
|
contig00840 |
ribosomal protein l22 |
446 |
20 |
8.30E-49 |
95.65% |
6 |
F:heparin binding; P:ribosome biogenesis; F:structural constituent of ribosome; F:RNA binding; C:cytosolic large ribosomal subunit; P:translation |
EC:3.6.5.3 |
|
contig00841 |
nucleoporin 160kda |
605 |
20 |
4.34E-40 |
75.85% |
6 |
C:nuclear pore; F:acid phosphatase activity; P:mRNA export from nucleus; F:nucleocytoplasmic transporter activity; F:protein binding; P:protein transport |
EC:3.1.3.2 |
|
contig00842 |
jun b proto-oncogene |
297 |
20 |
4.70E-28 |
74.40% |
7 |
F:sequence-specific DNA binding; P:response to cadmium ion; F:protein dimerization activity; F:transcription factor activity; C:nucleus; P:response to methylmercury; P:regulation of transcription, DNA-dependent |
|
|
contig00843 |
---NA--- |
1270 |
0 |
|
|
0 |
|
|
|
contig00844 |
---NA--- |
799 |
0 |
|
|
0 |
|
|
|
contig00845 |
proteolipid protein 1b |
859 |
20 |
5.92E-84 |
73.90% |
1 |
C:integral to membrane |
|
|
contig00846 |
mannose- 1 |
657 |
20 |
3.93E-11 |
88.70% |
11 |
P:protein folding; C:integral to membrane; C:Golgi membrane; F:mannose binding; C:ER-Golgi intermediate compartment membrane; P:ER to Golgi vesicle-mediated transport; F:unfolded protein binding; C:endoplasmic reticulum membrane; P:protein transport; P:blood coagulation; C:sarcomere |
|
|
contig00847 |
growth differentiation factor 3 |
1277 |
20 |
1.82E-155 |
64.50% |
10 |
F:morphogen activity; P:determination of left/right symmetry; P:mesoderm formation; F:receptor binding; P:cellular process; P:anterior/posterior pattern formation; C:extracellular region; F:protein heterodimerization activity; F:growth factor binding; F:protein homodimerization activity |
|
|
contig00848 |
ribosomal protein s10 |
550 |
20 |
2.19E-71 |
95.70% |
5 |
F:structural constituent of ribosome; F:RNA binding; F:protein binding; C:cytosolic small ribosomal subunit; P:translation |
EC:3.6.5.3 |
|
contig00849 |
double-stranded rna activated protein kinase |
1078 |
20 |
3.25E-75 |
62.70% |
2 |
F:left-handed Z-DNA binding; F:kinase activity |
|
|
contig00850 |
---NA--- |
501 |
0 |
|
|
0 |
|
|
|
contig00851 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig00852 |
zinc finger protein c3h type-like 2 |
1170 |
20 |
2.54E-76 |
58.10% |
5 |
C:cytoplasm; P:regulation of mRNA stability; F:nucleic acid binding; C:nucleus; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
|
|
contig00853 |
novel protein |
2983 |
20 |
5.65E-101 |
54.40% |
3 |
F:binding; P:P; C:C |
|
|
contig00854 |
adenosine trna-specific 1 |
274 |
20 |
1.50E-24 |
73.75% |
4 |
F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity; P:tRNA processing |
|
|
contig00855 |
mical-like 2 |
353 |
20 |
8.32E-25 |
73.20% |
5 |
F:metal ion binding; C:tight junction; ; F:protein binding; P:endocytosis |
|
|
contig00856 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig00857 |
chromosome 14 open reading frame isoform cra_a |
896 |
20 |
6.00E-34 |
67.95% |
2 |
F:F; C:C |
|
|
contig00858 |
raly rna binding isoform 2 |
317 |
20 |
1.14E-21 |
83.15% |
2 |
F:nucleotide binding; F:RNA binding |
|
|
contig00859 |
wd repeat domain 74 |
569 |
20 |
3.79E-69 |
67.80% |
3 |
P:P; C:nucleus; C:C |
|
|
contig00860 |
class type member 1 |
354 |
20 |
4.98E-54 |
94.20% |
12 |
P:bile acid and bile salt transport; C:brush border membrane; F:ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; C:membrane fraction; F:ATP binding; P:phospholipid transport; P:bile acid metabolic process; F:magnesium ion binding; C:apical plasma membrane; F:phospholipid-translocating ATPase activity; P:negative regulation of transcription; C:integral to plasma membrane |
EC:3.6.3.1 |
|
contig00861 |
eukaryotic translation initiation factor subunit 6 interacting protein |
1099 |
20 |
2.37E-159 |
98.00% |
4 |
C:fibrillar center; C:nucleoplasm; F:protein binding; P:translation |
EC:3.6.5.3 |
|
contig00862 |
dna methyltransferase 1 associated protein 1 |
818 |
20 |
4.02E-108 |
81.65% |
10 |
P:chromatin modification; P:regulation of cell growth; F:DNA binding; F:transcription corepressor activity; C:replication fork; P:retina development in camera-type eye; P:negative regulation of transcription, DNA-dependent; P:DNA methylation; F:methyltransferase activity; C:nucleus |
EC:2.1.1.0 |
|
contig00863 |
---NA--- |
530 |
0 |
|
|
0 |
|
|
|
contig00864 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig00865 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
contig00866 |
ribosomal protein l37a |
439 |
20 |
4.45E-47 |
97.25% |
6 |
C:cytosolic ribosome; P:ribosome biogenesis; F:structural constituent of ribosome; F:protein binding; F:zinc ion binding; P:translation |
EC:3.6.5.3 |
|
contig00867 |
rna binding motif protein 34 |
1582 |
20 |
6.13E-66 |
75.90% |
1 |
F:nucleic acid binding |
|
|
contig00868 |
heat shock protein 1 |
1001 |
20 |
1.46E-18 |
99.35% |
26 |
C:membrane raft; P:response to lipopolysaccharide; F:chaperone binding; P:protein folding; P:response to hydrogen peroxide; F:insulin binding; C:mitochondrial matrix; P:response to ATP; C:secretory granule; C:mitochondrial inner membrane; P:response to estrogen stimulus; C:Golgi apparatus; P:fin regeneration; P:positive regulation of anti-apoptosis; C:cytosol; F:protein heterodimerization activity; P:response to hypoxia; F:unfolded protein binding; P:response to drug; F:protease binding; P:response to heat; P:positive regulation of inflammatory response; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; C:rough endoplasmic reticulum; F:ATP binding; P:response to cocaine |
|
|
contig00869 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig00870 |
---NA--- |
433 |
0 |
|
|
0 |
|
|
|
contig00871 |
coiled-coil domain containing 25 |
954 |
20 |
2.20E-53 |
90.55% |
2 |
F:F; C:C |
|
|
contig00872 |
---NA--- |
1262 |
0 |
|
|
0 |
|
|
|
contig00873 |
novel protein vertebrate yip1 interacting factor homolog b ( cerevisiae) ( zgc:103562) |
715 |
20 |
4.61E-83 |
83.20% |
1 |
C:integral to membrane |
|
|
contig00874 |
hbv 1-transactivated protein 3 |
622 |
20 |
1.94E-38 |
73.25% |
2 |
P:P; C:C |
|
|
contig00875 |
---NA--- |
142 |
0 |
|
|
0 |
|
|
|
contig00876 |
kinetochore associated 2 |
2335 |
20 |
0 |
67.20% |
4 |
P:mitotic sister chromatid segregation; F:protein binding; C:nucleus; C:chromosome, centromeric region |
|
|
contig00877 |
tetratricopeptide repeat domain 39a |
443 |
20 |
5.03E-62 |
84.35% |
1 |
F:nucleic acid binding |
|
|
contig00878 |
programmed cell death 5 |
1300 |
20 |
8.94E-49 |
91.45% |
2 |
F:DNA binding; P:induction of apoptosis |
|
|
contig00879 |
fanconi complementation group l |
625 |
20 |
2.17E-37 |
89.15% |
8 |
C:cytoplasm; F:protein binding; P:zinc ion transport; P:ubiquitin cycle; F:ubiquitin-protein ligase activity; C:nucleus; F:zinc ion binding; P:DNA repair |
EC:6.3.2.19 |
|
contig00880 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
contig00881 |
transducin -like 3 |
567 |
20 |
3.30E-81 |
80.40% |
5 |
F:receptor signaling protein activity; C:small-subunit processome; P:G-protein signaling, coupled to cGMP nucleotide second messenger; P:rRNA processing; P:proteolysis |
|
|
contig00882 |
---NA--- |
433 |
0 |
|
|
0 |
|
|
|
contig00883 |
tropomyosin 2 |
338 |
20 |
7.41E-26 |
83.90% |
4 |
F:actin binding; C:muscle thin filament tropomyosin; F:structural constituent of cytoskeleton; P:muscle contraction |
|
|
contig00884 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig00885 |
synaptotagmin cytoplasmic rna interacting protein |
474 |
20 |
1.90E-29 |
97.70% |
8 |
C:microsome; P:RNA splicing; C:spliceosomal complex; F:protein binding; F:poly(A) RNA binding; P:mRNA processing; C:endoplasmic reticulum; F:nucleotide binding |
|
|
contig00886 |
---NA--- |
764 |
0 |
|
|
0 |
|
|
|
contig00887 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
contig00888 |
telomerase reverse transcriptase |
510 |
20 |
6.36E-66 |
67.40% |
6 |
F:DNA binding; P:RNA-dependent DNA replication; F:RNA binding; F:telomeric template RNA reverse transcriptase activity; C:nucleus; C:intracellular organelle part |
|
|
contig00889 |
---NA--- |
547 |
0 |
|
|
0 |
|
|
|
contig00890 |
---NA--- |
635 |
0 |
|
|
0 |
|
|
|
contig00891 |
---NA--- |
437 |
0 |
|
|
0 |
|
|
|
contig00892 |
testis-specific protein kinase 2 |
255 |
4 |
1.49E-13 |
64.25% |
0 |
|
|
|
contig00893 |
hexosaminidase (glycosyl hydrolase family catalytic domain) containing |
604 |
20 |
6.82E-94 |
68.25% |
2 |
F:cation binding; F:catalytic activity |
|
|
contig00894 |
glutamine-rich 1 |
287 |
20 |
8.10E-44 |
85.40% |
2 |
F:protein binding; C:intracellular |
|
|
contig00895 |
acidic coiled-coil containing protein 3 |
2552 |
20 |
0 |
55.15% |
1 |
F:protein binding |
|
|
contig00896 |
chromosome 9 open reading frame 64 |
321 |
20 |
2.58E-38 |
78.90% |
2 |
F:F; C:C |
|
|
contig00897 |
mitogen-activated protein kinase 14 |
1171 |
20 |
5.70E-52 |
90.25% |
20 |
P:angiogenesis; P:response to lipopolysaccharide; P:chondrocyte differentiation; P:skeletal muscle tissue development; F:protein C-terminus binding; F:MP kinase activity; P:protein amino acid autophosphorylation; P:embryonic cleavage; P:lipopolysaccharide-mediated signaling pathway; C:cytosolic part; P:DNA damage checkpoint; P:fatty acid oxidation; P:glucose metabolic process; P:positive regulation of erythrocyte differentiation; P:response to muramyl dipeptide; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleus; F:ATP binding; C:spindle pole; P:stress-activated MAPK cascade |
|
|
contig00898 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig00899 |
mannosyl (alpha- -)-glycoprotein beta- -n-acetylglucosaminyltransferase |
528 |
20 |
1.23E-94 |
90.70% |
8 |
C:Golgi membrane; F:alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; F:sugar binding; C:membrane fraction; C:Golgi stack; P:oligosaccharide biosynthetic process; C:integral to membrane; P:protein amino acid N-linked glycosylation via asparagine |
EC:2.4.1.143 |
|
contig00900 |
rna binding motif protein 28 |
344 |
20 |
4.61E-31 |
63.05% |
1 |
F:binding |
|
|
100 Rows returned.